21
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Changes of Soluble ICAM-1 Levels in Serum and Bronchoalveolar Lavage Fluid from Patients with Atopic Bronchial Asthma After Allergen Challenge

, &
Pages 405-412 | Published online: 02 Jul 2009
 

Abstract

Leukocyte-endothelial cell interaction is essential for leukocyte infiltration into inflammatory sites. Initiation of adhesion is through the up-regulated expression of adhesion molecules in the endothelium or epithelium and the activation of adhesion molecules on leukocytes. To our knowledge, there have been few reports concerning soluble intercellular adhesion molecule-1 (s1CAM-1) in patients with atopic bronchial asthma after allergen challenge. If the levels of s1CAM-1 vary between bronchial asthma patients and normal controls, this variance would be useful to assess the state of this disease. Therefore, we measured the levels of s1CAM-1 in sera from 17 patients with atopic bronchial asthma and normal control subjects. Levels of s1CAM-1 in sera from bronchial asthma patients in prechallenge conditions were higher than in normal control subjects. Levels of s1CAM-1 in sera from bronchial asthma patients 8 hr after challenge were higher than those in sera obtained during prechallenge periods. s1CAM-1 levels in bronchoalveolar lavage (BAL) fluids from bronchial asthma patients 8 hr after challenge were higher than at 30 min after challenge. These results suggest that higher levels of s1CAM-1 in sera and BAL fluids reflect the up-regulation of ICAM-1 expression in allergic bronchial asthma and these high levels may contribute to the pathogenesis of atopic bronchial asthma.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.